Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the ...

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from ...

They generally work a regular 40-hour week, but may be on call on some nights, weekends and holidays. Cardiovascular Perfusion programs are highly competitive and there are only 17 programs in the ...

Stifel analysts maintained a Buy rating and a $72.00 price target for LivaNova (NASDAQ:LIVN), following news from Swedish ...

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and the release of a short-seller report. Read more here.

This blended learning programme integrates academic knowledge and understanding of perfusion science with both the needs of the working professional clinical perfusion scientist and the demands of ...

The data revealed that the use of the Trans-Arterial Micro-Perfusion (TAMP) device resulted in greater drug potency and fewer ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...